Full Text View
Tabular View
No Study Results Posted
Related Studies
SPIRIT V: Post-Marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe
This study is ongoing, but not recruiting participants.
Study NCT00402272   Information provided by Abbott Vascular
First Received: November 17, 2006   Last Updated: May 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Disease
Coronary Artery Disease
Coronary Restenosis
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Coronary Stenosis
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Additional drug interventions recognized in this trial
Everolimus
Paclitaxel
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Abbott Vascular


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services